Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novo-Nordisk A/S

58.08
-4.8000-7.63%
Pre-market: 58.530.4500+0.77%07:15 EDT
Volume:32.22M
Turnover:1.88B
Market Cap:257.82B
PE:18.49
High:59.06
Open:57.91
Low:57.28
Close:62.88
Loading ...

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic's Competition Grows -- Barrons.com

Dow Jones
·
19 Apr

Novo Nordisk downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
18 Apr

Novo Nordisk downgraded by BMO as Eli Lilly gains ground in weight-loss drug race

Investing.com
·
18 Apr

Jefferies Sticks to Its Sell Rating for Novo Nordisk (0QIU)

TIPRANKS
·
18 Apr

J.P. Morgan Sticks to Its Buy Rating for Novo Nordisk (0QIU)

TIPRANKS
·
18 Apr

Novo Nordisk's ADRs Slide After Eli Lilly Obesity Pill Results -- Market Talk

Dow Jones
·
17 Apr

Eli Lilly's weight loss pill could be just as good as Ozempic — and the stock soars

Quartz
·
17 Apr

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live
·
17 Apr

Stock Track | Novo Nordisk Plummets 8% Pre-market on Analyst Downgrade and Rival's Breakthrough in Weight Loss Market

Stock Track
·
17 Apr

Stock Track | Novo Nordisk Plummets 8.08% as Analyst Downgrades and Rival's Breakthrough Shake Investor Confidence

Stock Track
·
17 Apr

Eli Lilly Shares Soar 14% as Lilly Pill Leads To 7.9% Weight Loss In Late-Stage Trial

Reuters
·
17 Apr

Stock Track | Novo Nordisk Plunges 7.57% Pre-market on Analyst Downgrade and Rival's Breakthrough

Stock Track
·
17 Apr

BMO Capital Downgrades Novo Nordisk to Market Perform From Outperform, Adjusts Price Target to $64 From $105

MT Newswires Live
·
17 Apr

Novo Nordisk Cut to Market Perform From Outperform by BMO Capital

Dow Jones
·
17 Apr

Novo Nordisk : Bmo Cuts to Market Perform From Outperform; Cuts Target Price to $64 From $105

THOMSON REUTERS
·
17 Apr

Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch

Benzinga
·
17 Apr

Novo Nordisk downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
17 Apr

Analysts Conflicted on These Healthcare Names: Novo Nordisk (NVO) and Sanofi (OtherSNYNF)

TIPRANKS
·
17 Apr

Novo Nordisk A/S (NVO): A Bull Case Theory

Insider Monkey
·
17 Apr

Novo Nordisk price target lowered to DKK 700 from DKK 900 at Barclays

TIPRANKS
·
17 Apr